NDI-219216 clinical trials

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

This study is testing a new medicine, NDI-219216, for people with advanced solid cancers. Researchers want to see if it's safe, what side effects it might cause, and if it could help shrink tumours. It's an early-stage trial.